Prenetics Global Limited Receivables Turnover Ratio (PRE), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Prenetics Global Limited  (NASDAQ: PRE)
 

Prenetics Global Limited Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Prenetics Global Limited's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 30.82, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Prenetics Global Limited in Dec 31 2025 quarter, has decreased to 12 days, compared to 43 days, in the 0 quarter.

If we take a look into Healthcare sector 154 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 1558.

What is Receivable Turnover Ratio?
What is Prenetics Global Limited Selling?


What is Receivable Turnover Ratio?





PRE Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Receivable Change -43.19 % -43.19 % -43.19 % -43.19 % 29.18 %
Y / Y Revenue Change 201.94 % - - - 39.82 %
Receivable Turnover Ratio (TTM) 30.82 8.58 7.4 6.5 5.8
PRE's Total Ranking # 1558 # 0 # # #
Accounts Receivable average collection period days 12 43 49 56 63
Seq. Receivable Change 0 % 0 % 0 % -43.19 % 0 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 4
Healthcare Sector # 155
Overall Market # 1558

Receivable Turnover Ratio Statistics
High Average Low
9.51 5.04 2.57
(Dec 31 2025)   (Dec 31 2024)






Financial Statements
Prenetics Global Limited's Accounts Receivable $ 3 Millions Visit PRE's Balance sheet
Prenetics Global Limited's Sales TTM $ 92 Millions Visit PRE's Income Statement
Sources of PRE's Revenues Visit PRE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRE's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRE's Growth Rates PRE's Roa PRE's Inventory Turnover Ratio PRE's Dividend Comparisons
PRE's Profitability Ratios PRE's Roi PRE's Asset Turnover Ratio PRE's Dividend Growth
PRE's Valuation Ratios PRE's Roe PRE's Financial Strength Ratios PRE's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Sbc Medical Group Holdings Incorporated  76.66 $ 171.922  Millions$ 2.243  Millions
Aclaris Therapeutics Inc   70.50 $ 7.826  Millions$ 0.111  Millions
Agape Atp Corporation  70.27 $ 1.524  Millions$ 0.022  Millions
Humacyte Inc   67.98 $ 40.803  Millions$ 0.600  Millions
Airsculpt Technologies Inc   59.97 $ 151.818  Millions$ 2.532  Millions
Spero Therapeutics Inc   56.29 $ 66.802  Millions$ 1.187  Millions
Crinetics Pharmaceuticals Inc   52.00 $ 7.696  Millions$ 0.148  Millions
Brookdale Senior Living Inc   51.27 $ 3,194.066  Millions$ 62.298  Millions
Eyepoint Inc   45.42 $ 31.371  Millions$ 0.691  Millions
X4 Pharmaceuticals Inc  45.05 $ 35.113  Millions$ 0.780  Millions
Fortrea Holdings Inc   44.55 $ 2,723.400  Millions$ 61.125  Millions
Longduoduo Co Ltd  44.55 $ 2.722  Millions$ 0.061  Millions
Lifevantage Corp  44.29 $ 208.401  Millions$ 4.705  Millions
Valion Bio Inc   42.84 $ 0.482  Millions$ 0.011  Millions
Kyntra Bio Inc   41.55 $ 6.440  Millions$ 0.155  Millions
Cytomx Therapeutics Inc   40.82 $ 76.201  Millions$ 1.867  Millions
Solana Company  40.38 $ 6.017  Millions$ 0.149  Millions
Atara Biotherapeutics Inc   40.31 $ 121.355  Millions$ 3.010  Millions
Nature s Sunshine Products inc   39.85 $ 479.724  Millions$ 12.040  Millions
National Vision Holdings Inc   39.24 $ 1,987.488  Millions$ 50.646  Millions
Lineage Cell Therapeutics Inc   39.16 $ 14.556  Millions$ 0.372  Millions
Monte Rosa Therapeutics Inc   37.07 $ 123.672  Millions$ 3.336  Millions
Meiragtx Holdings Plc  36.74 $ 81.391  Millions$ 2.215  Millions
Protagonist Therapeutics inc   35.26 $ 46.016  Millions$ 1.305  Millions
Stoke Therapeutics Inc   35.18 $ 184.420  Millions$ 5.243  Millions
Genmab A  32.63 $ 3,720.000  Millions$ 114.000  Millions
Agenus Inc  32.27 $ 114.196  Millions$ 3.539  Millions
Metagenomi Therapeutics Inc   32.01 $ 25.210  Millions$ 0.788  Millions
U S Physical Therapy Inc  30.83 $ 780.990  Millions$ 25.331  Millions
Invo Fertility Inc   30.16 $ 6.841  Millions$ 0.227  Millions

Date modified: 2026-07-07T12:49:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.